Winshine Science : (1)FURTHER DELAY IN DESPATCH OF 2018 ANNUAL REPORT; (2)FURTHER DELAY IN PUBLICATION OF 2019 INTERIM RESULTS; (3)FURTHER DELAY IN DESPATCH OF 2019 INTERIM REPORT; AND (4)UPDATE ON SUSPENSION OF TRADING

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

WINSHINE SCIENCE COMPANY LIMITED

瀛 晟 科 學 有 限 公 司 *

(Incorporated in Bermuda with limited liability)

(Stock Code: 209)

1. (1) FURTHER DELAY IN DESPATCH OF 2018 ANNUAL REPORT;

2. FURTHER DELAY IN PUBLICATION OF 2019 INTERIM RESULTS; (3)FURTHER DELAY IN DESPATCH OF 2019 INTERIM REPORT;

AND

(4) UPDATE ON SUSPENSION OF TRADING

This announcement is made by the board (the "Board") of directors (the "Directors") of Winshine Science Company Limited (the "Company", together with its subsidiaries, the "Group") pursuant to Rules 13.09 and 13.49(6) of The Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited (the "Stock Exchange") (the

• Listing Rules") and the provisions of inside information under Part XIVA of the Securities and Futures Ordinance (Chapter 571 of the Laws of Hong Kong).

References are made to the announcements of the Company dated 28 March 2019, 16 April 2019, 19 June 2019, 25 June 2019, 2 September 2019, 2 October 2019 and 30 October in relation to, among other things, (i) the delay in publication of the annual results of the Group for the year ended 31 December 2018 (the "2018 Annual Results");

1. the delay in despatch of the annual report of the Group for the year ended 31 December 2018 (the "2018 Annual Report"); (iii) the delay in publication of the interim results of the Group for the six months ended 30 June 2019 (the "2019 Interim Results"); (iv) the delay in despatch of the interim report of the Group for the six months ended 30 June 2019 (the "2019 Interim Report"); (v) the resumption guidance issued by the Stock Exchange (the "Resumption Guidance"); (vi) suspension of trading in the shares (the "Shares") of the Company on the Stock Exchange with effect from 9:00 a.m. on 1 April 2019; (vii) key findings of the independent investigation and (viii) results of internal control review (collectively, the "Announcements"). Unless otherwise defined, terms used in this announcement shall have the same meanings as those defined in the Announcements.

1

FURTHER DELAY IN DESPATCH OF 2018 ANNUAL REPORT

As disclosed in the announcement of the Company dated 2 October 2019, it was expected that the 2018 Annual Results and the 2018 Annual Report will be issued by the end of October 2019.

On 30 October 2019, the Company has published the 2018 Annual Results. However, as additional time is required for bulk printing of the 2018 Annual Report, it is expected that the despatch of 2018 Annual Report will be further postponed to a date falling on or before 4 November 2019.

FURTHER DELAY IN PUBLICATION OF 2019 INTERIM RESULTS AND DESPATCH OF 2019 INTERIM REPORT

As disclosed in the announcement of the Company dated 2 October 2019, it was expected that the 2019 Interim Results and 2019 Interim Report will be issued by the end of October 2019. However, as additional time is required for the Company to finalise 2019 Interim Results and bulk printing of 2019 Interim Report, it is expected that publication of 2019 Interim Results and despatch of 2019 Interim Report will be further postponed to a date falling on or before 6 November 2019 and 12 November 2019 respectively.

As disclosed in the announcement dated 25 October 2019, a board meeting of the Company will be held on Wednesday, 6 November 2019 for the purpose of, inter alia, approving the interim results of the Company and its subsidiaries for the six months ended 30 June 2019 and the recommendation of an interim dividend, if any.

UPDATE ON SUSPENSION OF TRADING

The Board would like to update the Shareholders on matters pertaining to the Resumption Guidance. As disclosed in the announcement of the Company dated 30 October 2019, the Company has published the key findings of the independent investigation conducted by FTI Consulting and the results of the internal control review conducted by the Internal Control Adviser on 30 October 2019.

CONTINUED SUSPENSION OF TRADING

At the request of the Company, trading in the Shares on the Stock Exchange has been suspended since 9:00 a.m. on 1 April 2019 and will remain suspended until further notice pending fulfilment of the Resumption Guidance.

2

Shareholders and potential investors of the Company are advised to exercise caution when dealing in the shares of the Company.

By Order of the Board

Winshine Science Company Limited

Zhao Deyong

Chairman

Hong Kong, 1 November 2019

As at the date of this announcement, the Board comprises three Executive Directors, namely Mr. Zhao Deyong (Chairman), Mr. Liu Michael Xiao Ming (Chief Executive Officer) and Mr. Luo Lianjun; one Non-executive Director, namely Mr. Lin Shaopeng; and three Independent Non-executive Directors, namely Mr. Kwok Kim Hung Eddie, Mr. Ng Wai Hung and Ms. Shi Xiaolei.

• For identification purpose only

3